반응식
Cl[CH2:2][CH2:3][S:4]([C:7]1[CH:12]=[CH:11][C:10]([OH:13])=[CH:9][CH:8]=1)(=[O:6])=[O:5].[C:14]1([CH3:27])[CH:19]=[CH:18][C:17]([O:20][CH:21]2[CH2:26][CH2:25][NH:24][CH2:23][CH2:22]2)=[CH:16][CH:15]=1>>[C:14]1([CH3:27])[CH:15]=[CH:16][C:17]([O:20][CH:21]2[CH2:26][CH2:25][N:24]([CH2:2][CH2:3][S:4]([C:7]3[CH:12]=[CH:11][C:10]([OH:13])=[CH:9][CH:8]=3)(=[O:6])=[O:5])[CH2:23][CH2:22]2)=[CH:18][CH:19]=1참가 물질
3
실험 절차
The title compound was prepared from 4-(2-chloro-ethanesulfonyl)-phenol and 4-p-tolyloxy-piperidine (prepared according to J. Med. Chem., 1978, 21, 309) in 59% yield as a white solid.
출처 및 근거
- ORD 기록
- ord-58cfce06e89b482a8455df997ba41a8f
- 출처 데이터셋
- uspto-grants-2001_10
- 특허 번호
- US06310213B1
연결된 노트
불러오는 중…